RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies
scientific article published on 16 October 2007
Author/s
author: Heli Nevanlinna, Georgia Chenevix-Trench, Peter Devilee, Dominique Stoppa-Lyonnet, Adalgeir Arason, Tomas Kirchhoff, Norbert Arnold, Jeffery Struewing, Ana Osorio, Michal Zikán, Christoph Engel, Nicole Cloonan, Katherine L Nathanson, Amanda Spurdle, Tomasz Byrski, Anna Jakubowska, Nicola J Waddell, Susan M Domchek, Jan Lubiński, Alfons Meindl, Rita Schmutzler, Susan L Neuhausen, Olufunmilayo Olopade, Douglas F. Easton, Fergus J. Couch, Ute Hamann, Kenneth Offit, Jacques Simard, Irene L Andrulis, Jeffrey N Weitzel, Javier Benitez, Steven A. Narod, Gad Rennert, Claudine Isaacs, Antonis C Antoniou, Yael Laitman, Eitan Friedman, Tomasz Huzarski, Jacek Gronwald, Bohdan Górski, John Burn, Andrew K Godwin, Timothy R Rebbeck, Dieter Niederacher, Outi Kilpivaara, Mark H Greene, Olga M Sinilnikova, Beatrix Versmold, Susan Peock, Laure Barjhoux, Yves-Jean Bignon, Helmut Deissler, Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), Maaike Pg Vreeswijk, Valérie Bonadona, Mélanie Léoné, Gail E Tomlinson, Christine Lasset, Isabelle Coupier, Flavio Lejbkowicz, Leon Raskin, Huw Dorkins, Muriel Belotti, Theresa Maria Wagner, Eduard Ilyushik, Judy E. Garber
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.